PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-15.27%
Negative net income growth while 3088.T stands at 1045.55%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
10.12%
D&A growth well above 3088.T's 3.59%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-139.01%
Both reduce yoy usage, with 3088.T at -231.50%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-215.97%
Both reduce yoy inventory, with 3088.T at -2388.78%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-108.33%
Both reduce yoy usage, with 3088.T at -144.35%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
108.35%
Lower 'other non-cash' growth vs. 3088.T's 253.37%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-50.98%
Negative yoy CFO while 3088.T is 152.59%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-44.44%
Negative yoy CapEx while 3088.T is 11.48%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-103.94%
Both yoy lines negative, with 3088.T at -386.87%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-49.13%
Both yoy lines negative, with 3088.T at -21.87%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-31.29%
We cut debt repayment yoy while 3088.T is 22.13%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.